Samir V. Jenkins

High Impact

Researcher

University of Arkansas for Medical Sciences

faculty

21 h-index 73 pubs 1,379 cited

Research Areas

Nanoparticles: synthesis and applications Cancer Treatment and Pharmacology Cancer-related molecular mechanisms research Drug-Induced Hepatotoxicity and Protection Nanoplatforms for cancer theranostics Neuroscience and Neuropharmacology Research Immune Response and Inflammation MicroRNA in disease regulation

Links

ORCID Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Samir V. Jenkins' research focuses on the development and application of nanomedicines for targeted therapeutic interventions, particularly in the context of cancer and neural stem cell differentiation. His work investigates how nanomaterials can enhance drug delivery, improve photothermal therapy, and modulate cellular responses. Recent publications explore the use of ionic nanomaterials for combination therapy, the photothermal effects of gold nanostructure-coated surfaces, and the role of exosomal profiles in hepatocellular carcinoma.

Jenkins also studies the mechanisms of therapeutic action at a molecular level. This includes examining bystander effects in radiation therapy and the cellular pathways involved in drug uptake for nanomedicine formulations. His research network includes collaborators from the University of Arkansas at Fayetteville and the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications. Jenkins leads a research group and has a scholarly profile marked by 73 publications and 1,379 citations, with an h-index of 21, indicating significant contributions in his field.

Metrics

h-index: 21
Publications: 73
Citations: 1,379

Selected Publications

Modified tumor uptake and biodistribution of nanoparticles coated with small extracellular vesicle membranes derived from distinct tumor cell lines (2026) DOI
CB-839 induces reversible dormancy in lung tumor-cells (2024) DOI
Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024) DOI
Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications (2024) DOI
Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A (2024) DOI
Morphological Effects and In Vitro Biological Mechanisms of Radiation-Induced Cell Killing by Gold Nanomaterials (2023) DOI
Exosomal MicroRNA and Protein Profiles of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells (2023) DOI
General principles of SFRT biology (2023) DOI
Proteomic analysis of transcription factors involved in the alteration of ischemic mouse heart as modulated by MSC exosomes (2023) DOI
Proteomic Analysis of Transcription Factors Involved in the Alteration of Ischemic Mouse Heart as Modulated by MSC Exosomes (2023) DOI
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy (2022) DOI
β-Glucosidase Immobilized on Magnetic Nanoparticles: Controlling Biomolecule Footprint and Particle Functional Group Density to Navigate the Activity–Stability Tradeoff (2022) DOI
Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy (2022) DOI
Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy (2022) DOI
Abstract 3529: T-cell trafficking and extravasation is suppressed in distal tumors during gastrointestinal tract dysbiosis (2022) DOI